Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 2

    1.

    Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.

    Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S; DREAM investigators.

    Diabetes Care. 2010 Oct;33(10):2250-3. Epub 2010 Jul 13.

    PMID:
    20628086
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.

    RuaƱo G, Bernene J, Windemuth A, Bower B, Wencker D, Seip RL, Kocherla M, Holford TR, Petit WA, Hanks S.

    Clin Chim Acta. 2009 Feb;400(1-2):48-55. Epub 2008 Oct 26.

    PMID:
    18996102
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk